Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.
作者信息
Farhadnejad Hossein, Saber Niloufar, Neshatbini Tehrani Asal, Kazemi Jahromi Mitra, Mokhtari Ebrahim, Norouzzadeh Mostafa, Teymoori Farshad, Asghari Golaleh, Mirmiran Parvin, Azizi Fereidoun
机构信息
Nutrition and Endocrine Research Center Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Student Research Committee Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
出版信息
J Nutr Metab. 2024 Jul 10;2024:8300428. doi: 10.1155/2024/8300428. eCollection 2024.
Type 2 diabetes (T2D) is known as a major public health problem with a noticeable adverse impact on quality of life and health expenditures worldwide. Despite using routine multiple pharmacological and nonpharmacological interventions, including diet therapy and increasing physical activity, controlling this chronic disease remains a challenging issue, and therapeutic goals are often not achieved. Therefore, recently, other therapeutic procedures, such as using herbal products and functional foods as complementary or alternative medicine (CAM), have received great attention as a new approach to managing T2D complications, according to the literature. We reviewed the existing evidence that supports using various fundamental medicinal herbs, including cinnamon, saffron, ginger, jujube, turmeric, and barberry, as CAM adjunctive therapeutic strategies for T2D patients. The current review addressed different aspects of the potential impact of the abovementioned herbal products in improving glycemic indices and lipid profiles, including the effect size reported in the studies, their effective dose, possible side effects, herbs-drug interactions, and their potential action mechanisms.
相似文献
Ont Health Technol Assess Ser. 2009
Curr Drug Metab. 2023
Curr Treat Options Gastroenterol. 2017-12
J Ethnopharmacol. 2015-12-4
引用本文的文献
Pharmaceuticals (Basel). 2025-7-31
本文引用的文献
J Clin Med. 2023-5-11
Front Pharmacol. 2022-11-16
Evid Based Complement Alternat Med. 2022-6-17
Am J Clin Nutr. 2022-6-7